These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 9222076)
1. Oral bioavailability of trovafloxacin with and without food in healthy volunteers. Teng R; Dogolo LC; Willavize SA; Friedman HL; Vincent J J Antimicrob Chemother; 1997 Jun; 39 Suppl B():87-92. PubMed ID: 9222076 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and safety of trovafloxacin in healthy male volunteers following administration of single intravenous doses of the prodrug, alatrofloxacin. Vincent J; Venitz J; Teng R; Baris BA; Willavize SA; Polzer RJ; Friedman HL J Antimicrob Chemother; 1997 Jun; 39 Suppl B():75-80. PubMed ID: 9222074 [TBL] [Abstract][Full Text] [Related]
3. Single- and multiple-dose administration, dosing regimens, and pharmacokinetics of trovafloxacin and alatrofloxacin in humans. Vincent J; Dogolo L; Baris BA; Willavize SA; Teng R Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):427-30. PubMed ID: 9758287 [TBL] [Abstract][Full Text] [Related]
4. Effect of Maalox and omeprazole on the bioavailability of trovafloxacin. Teng R; Dogolo LC; Willavize SA; Friedman HL; Vincent J J Antimicrob Chemother; 1997 Jun; 39 Suppl B():93-7. PubMed ID: 9222077 [TBL] [Abstract][Full Text] [Related]
5. Penetration of trovafloxacin into cerebrospinal fluid in humans following intravenous infusion of alatrofloxacin. Cutler NR; Vincent J; Jhee SS; Teng R; Wardle T; Lucas G; Dogolo LC; Sramek JJ Antimicrob Agents Chemother; 1997 Jun; 41(6):1298-300. PubMed ID: 9174187 [TBL] [Abstract][Full Text] [Related]
6. The bioavailability of nasogastric versus tablet-form oral trovafloxacin in healthy subjects. Vincent J; Teng R; Pelletier SM; Willavize SA; Friedman HL Am J Surg; 1998 Dec; 176(6A Suppl):23S-26S. PubMed ID: 9935253 [TBL] [Abstract][Full Text] [Related]
7. Oral bioavailability and pharmacokinetics of trovafloxacin in patients with AIDS. Lacy MK; Nicolau DP; Nightingale CH; Geffken A; Teng R; Vincent J; Quintiliani R Antimicrob Agents Chemother; 1999 Dec; 43(12):3005-7. PubMed ID: 10582898 [TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of intravenous-to-oral treatment and single-dose intravenous or oral prophylaxis with trovafloxacin. Williams DJ; Hopkins S Am J Surg; 1998 Dec; 176(6A Suppl):74S-79S. PubMed ID: 9935261 [TBL] [Abstract][Full Text] [Related]
9. Concentrations of trovafloxacin in colonic tissue and peritoneal fluid after intravenous infusion of the prodrug alatrofloxacin in patients undergoing colorectal surgery. Melnik G; Schwesinger WH; Dogolo LC; Teng R; Vincent J Am J Surg; 1998 Dec; 176(6A Suppl):14S-17S. PubMed ID: 9935251 [TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetic effects of coadministration of morphine and trovafloxacin in healthy subjects. Vincent J; Hunt T; Teng R; Robarge L; Willavize SA; Friedman HL Am J Surg; 1998 Dec; 176(6A Suppl):32S-38S. PubMed ID: 9935255 [TBL] [Abstract][Full Text] [Related]
11. Hepatobiliary elimination of trovafloxacin and metabolites following single oral doses in healthy volunteers. Melnik G; Schwesinger WH; Teng R; Dogolo LC; Vincent J Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):424-6. PubMed ID: 9758286 [TBL] [Abstract][Full Text] [Related]
12. An open, controlled, crossover study on the effects of cimetidine on the steady-state pharmacokinetics of trovafloxacin. Purkins L; Oliver SD; Willavize SA Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):431-3. PubMed ID: 9758288 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of trovafloxacin (CP-99,219), a new quinolone, in rats, dogs, and monkeys. Teng R; Girard D; Gootz TD; Foulds G; Liston TE Antimicrob Agents Chemother; 1996 Mar; 40(3):561-6. PubMed ID: 8851571 [TBL] [Abstract][Full Text] [Related]
14. The effect of food on the bioavailability of oral gemifloxacin in healthy volunteers. Allen A; Bygate E; Clark D; Lewis A; Pay V Int J Antimicrob Agents; 2000 Sep; 16(1):45-50. PubMed ID: 11185412 [TBL] [Abstract][Full Text] [Related]
15. Oral bioequivalence of three ciprofloxacin formulations following single-dose administration: 500 mg tablet compared with 500 mg/10 mL or 500 mg/5 mL suspension and the effect of food on the absorption of ciprofloxacin oral suspension. Shah A; Liu MC; Vaughan D; Heller AH J Antimicrob Chemother; 1999 Mar; 43 Suppl A():49-54. PubMed ID: 10225572 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of a fluoronaphthyridone, trovafloxacin (CP 99,219), in infants and children following administration of a single intravenous dose of alatrofloxacin. Bradley JS; Kearns GL; Reed MD; Capparelli EV; Vincent J Antimicrob Agents Chemother; 2000 May; 44(5):1195-9. PubMed ID: 10770751 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and safety of trovafloxacin (CP-99,219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers. Teng R; Harris SC; Nix DE; Schentag JJ; Foulds G; Liston TE J Antimicrob Chemother; 1995 Aug; 36(2):385-94. PubMed ID: 8522468 [TBL] [Abstract][Full Text] [Related]
18. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions. Chen C; Bujanover S; Kareht S; Rapoport AM Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and metabolism of single oral doses of trovafloxacin. Vincent J; Teng R; Dalvie DK; Friedman HL Am J Surg; 1998 Dec; 176(6A Suppl):8S-13S. PubMed ID: 9935250 [TBL] [Abstract][Full Text] [Related]
20. Multiple-dose pharmacokinetics and safety of trovafloxacin in healthy volunteers. Teng R; Liston TE; Harris SC J Antimicrob Chemother; 1996 May; 37(5):955-63. PubMed ID: 8737145 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]